Novocure
Dr. Verena Leidgens is an experienced professional with a strong background in biomedical sciences, neurology, and brain tumor research. Dr. Verena has held various roles in medical education and research at Novocure, the Department of Neurology at the University of Regensburg, and the Hubrecht Institute. Dr. Leidgens has a PhD in biomedical sciences from the University of Regensburg and a Master of Science in Molecular Cell Biology from Bielefeld University.
This person is not in the org chart
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.